Atopic Dermatitis Affects Millions, And Johnson & Johnson Is Committed To Addressing The Unmet Needs Of Patients
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...
Dear Doctor: What do long-term, large studies show about the use of statins for women’s health?
There remains controversy in the scientific community about the benefit of statins in women, because women have been less studied than men.
Innovative voice-based approach enables early detection of Alzheimer's disease
A multi-task learning framework, DEMENTIA, has been developed by Prof. Li Hai and his team at the Hefei Institutes of ...
Dr. Roach: With severe dementia, medications are of limited benefit
My 89-year-old husband was diagnosed with Alzheimer's disease. He does not take any medication. He is in excellent health except for the Alzheimer's. His blood pressure is 123/69 ...
Healio8d
Biomarkers may enable blood test for early Alzheimer’s disease, explain sex disparity
Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its ...
EurekAlert!9d
Acupuncture protects brain regions in an Alzheimer’s disease mouse model by inhibiting apoptosis and reducing tau protein
Acupuncture treatment on the DU channel has shown therapeutic effects for Alzheimer’s disease (AD), but the underlying mechanisms are not yet clear. The purpose of this study was to comprehensively ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
INDICATION LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with ...
Hosted on MSN3d
Prolonged REM Latency Potential Marker for Alzheimer Disease
Prolonged rapid eye movement (REM) latency may be a potential marker for Alzheimer disease and Alzheimer disease and related ...
IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer’s Disease
POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREPARE ...